616894-67-8

Upstream product

• 616894-52-1 1-{(3aR,4R,6R,6aR)-6-[(2S,3R)-3-(2,3-Dihydro-indole-1-carbonyl)-oxiranyl]-2,2-dimethyl-tetrahydro-furo[3,4-d][1,3]dioxol-4-yl}-3-(4-methoxy-benzyl)-1H-pyrimidine-2,4-dione 
• 616894-53-2 1-{(3aR,4R,6R,6aR)-6-[(2S,3R)-3-(Indole-1-carbonyl)-oxiranyl]-2,2-dimethyl-tetrahydro-furo[3,4-d][1,3]dioxol-4-yl}-3-(4-methoxy-benzyl)-1H-pyrimidine-2,4-dione 
• 121845-98-5 (3aR,4S,6R,6aS)-6-(3-(4-methoxybenzyl)-3,4-dihydro-2,4-dioxopyrimidin-1(2H)-yl)-tetrahydro-2,2-dimethylfuro[3,4-d][1,3]dioxole-4-carbaldehyde 
• 616894-66-7 (2R,3S)-3-{(3aR,4R,6R,6aR)-6-[3-(4-Methoxy-benzyl)-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl]-2,2-dimethyl-tetrahydro-furo[3,4-d][1,3]dioxol-4-yl}-oxirane-2-carboxylic acid allylamide 

Relevant academic research and scientific papers

A Convergent Synthetic Approach to the Nucleoside-Type Liposidomycin Antibiotics

(Matrix presented) A synthetic approach toward the liposidomycins, a family of complex nucleoside-type antibiotics, is reported based on the synthesis of epoxy-amides derived from the reaction of sulfur ylides with the uridyl aldehyde derivative 6. To thi